Salud financiera de hoja de balance de Sihuan Pharmaceutical Holdings Group
Salud financiera controles de criterios 3/6
Sihuan Pharmaceutical Holdings Group tiene un patrimonio de los accionistas total de CN¥5.1B y una deuda total de CN¥1.2B, lo que sitúa su ratio deuda-patrimonio en 22.9%. Sus activos y pasivos totales son CN¥11.5B y CN¥6.4B respectivamente.
Información clave
22.9%
Ratio deuda-patrimonio
CN¥1.17b
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CN¥4.37b |
| Patrimonio | CN¥5.14b |
| Total pasivo | CN¥6.40b |
| Activos totales | CN¥11.54b |
Actualizaciones recientes sobre salud financiera
Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?
Oct 31
Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Oct 11Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly
Sep 26Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Dec 21
Recent updates
Here's Why It's Unlikely That Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO Will See A Pay Rise This Year
May 31Investors Still Waiting For A Pull Back In Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
May 27A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Dec 05Health Check: How Prudently Does Sihuan Pharmaceutical Holdings Group (HKG:460) Use Debt?
Oct 31Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Aug 19Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Apr 21Is Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Worth HK$0.8 Based On Its Intrinsic Value?
Nov 03Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Oct 11Is There An Opportunity With Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) 34% Undervaluation?
Jun 21Estimating The Intrinsic Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Mar 09A Look At The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Nov 28Sihuan Pharmaceutical Holdings Group (HKG:460) Seems To Use Debt Rather Sparingly
Sep 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) CEO For Now
Jun 22How Does Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Fare As A Dividend Stock?
May 11Sihuan Pharmaceutical Holdings Group's (HKG:460) Shareholders May Want To Dig Deeper Than Statutory Profit
Mar 30How Much Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) Do Insiders Own?
Mar 07Should You Buy Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460) For Its Dividend?
Feb 07Estimating The Fair Value Of Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460)
Jan 11Does Sihuan Pharmaceutical Holdings Group (HKG:460) Have A Healthy Balance Sheet?
Dec 21Why Sihuan Pharmaceutical Holdings Group's (HKG:460) CEO Pay Matters
Dec 07Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥6.2B) de 460 superan a sus pasivos a corto plazo (CN¥4.1B).
Pasivo a largo plazo: Los activos a corto plazo de 460 (CN¥6.2B) superan a sus pasivos a largo plazo (CN¥2.3B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 460 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 460 ha crecido de 0.7% a 22.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de 460 no está bien cubierta por el flujo de caja operativo (17%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 460 sobre su deuda están bien cubiertos por el EBIT.